Frontiers in Oncology (Jun 2023)

Anticancer properties of sulforaphane: current insights at the molecular level

  • Muhammad Asif Ali,
  • Noohela Khan,
  • Nabeeha Kaleem,
  • Waqas Ahmad,
  • Salem Hussain Alharethi,
  • Bandar Alharbi,
  • Hassan H. Alhassan,
  • Maher M. Al-Enazi,
  • Ahmad Faizal Abdull Razis,
  • Ahmad Faizal Abdull Razis,
  • Babagana Modu,
  • Babagana Modu,
  • Daniela Calina,
  • Javad Sharifi-Rad

DOI
https://doi.org/10.3389/fonc.2023.1168321
Journal volume & issue
Vol. 13

Abstract

Read online

Sulforaphane (SFN) is an isothiocyanate with multiple biomedical applications. Sulforaphane can be extracted from the plants of the genus Brassica. However, broccoli sprouts are the chief source of sulforaphane and are 20 to 50 times richer than mature broccoli as they contain 1,153 mg/100 g. SFN is a secondary metabolite that is produced as a result of the hydrolysis of glucoraphanin (a glucosinolate) by the enzyme myrosinase. This review paper aims to summarize and understand the mechanisms behind the anticancer potential of sulforaphane. The data was collected by searching PubMed/MedLine, Scopus, Web of Science, and Google Scholar. This paper concludes that sulforaphane provides cancer protection through the alteration of various epigenetic and non-epigenetic pathways. It is a potent anticancer phytochemical that is safe to consume with minimal side effects. However, there is still a need for further research regarding SFN and the development of a standard dose.

Keywords